Abstract
BackgroundBreast metastasis in hematological malignancies is a rare phenomenon, and it is primarily seen in acute myeloid leukemia (AML). In patients with acute lymphoblastic leukemia (ALL), this condition is even rarer.Case presentation.We present a case of a precursor B cell ALL involving breast in a 40-year-old female and its imaging features on mammography and ultrasound. Histopathology of core needle biopsy (CNB) specimen allowed us to diagnose ALL with extramedullary metastases. The patient was referred to oncology for further management.ConclusionTo conclude, ALL infiltrating breast is rare but should be given due consideration, especially in the cases of known primary hematopoietic malignancy, particularly in patients presenting with a history of sudden lumps in the breast. A CNB can give reliable results in combination with flow cytometry and immunocytochemistry, circumventing the need for an excisional biopsy and allowing the commencement of early treatment.
Highlights
Conclusionacute lymphoblastic leukemia (ALL) infiltrating breast is rare but should be given due consideration, especially in the cases of known primary hematopoietic malignancy, in patients presenting with a history of sudden lumps in the breast
Breast metastasis in hematological malignancies is a rare phenomenon, and it is primarily seen in acute myeloid leukemia (AML)
To conclude, acute lymphoblastic leukemia (ALL) infiltrating breast is rare but should be given due consideration, especially in the cases of known primary hematopoietic malignancy, in patients presenting with a history of sudden lumps in the breast
Summary
ALL infiltrating breast is rare but should be given due consideration, especially in the cases of known primary hematopoietic malignancy, in patients presenting with a history of sudden lumps in the breast.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Egyptian Journal of Radiology and Nuclear Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
